1st batch of Pfizer COVID-19 vaccine arrives in Japan

1st batch of Pfizer COVID-19 vaccine arrives in Japan

An airplane carrying the first batch to arrive in Japan of the coronavirus vaccine developed by U.S. pharmaceutical giant Pfizer Inc. takes off from Brussels international airport on Feb. 11, 2021.

  • Product Code
  • ILEA000059949
  • Registered date
  • 2021/2/12 12:22:38
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2021 Kyodo News
  • Media size
  • 1015 × 715 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 138.47(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japan's top COVID-19 adviser Omi

    Japan's top COVID-19 adviser Omi

    Shigeru Omi, the Japanese government's top COVID-19 adviser, speaks to reporters after receiving his third shot of coronavirus vaccine at a mass vaccination center in Tokyo's Otemachi area on Feb. 5, 2022. (Pool photo)

      COVID quasi-emergency to cover 34 of Japan's 47 prefs. amid Omicron

      Japan will decide Tuesday to expand a COVID-19 quasi-state of emergency to 34 of the nation's 47 prefectures with the addition of 18 more areas to stem the rapid spread of the Omicron variant of the coronavirus. Effective from Thursday to Feb. 20, the quasi-emergency is intended to reduce the strain on the health care system and prevent a shortage of essential workers that could result from a surge in infections and close contacts. The governors of the 18 prefectures, including Osaka, Kyoto and Hyogo in the Kansai region in western Japan, will be able to request restaurants and bars to shorten their business hours and stop or limit the serving of alcohol. Prime Minister Fumio Kishida is expected to make a final decision later in the day on the addition as well as on extending the quasi-emergency curbs that have been in place since Jan. 9 in Okinawa, Yamaguchi and Hiroshima prefectures beyond Jan. 31 to Feb. 20.
        Japan's fight against coronavirus

        Japan's fight against coronavirus

        File photo taken in September 2021 shows people waiting in line to receive COVID-19 vaccine in Nagoya, central Japan.
          Japan begins administering COVID-19 booster shots

          Japan begins administering COVID-19 booster shots

          Noriko Horiuchi (2nd from L), Japanese minister in charge of promoting coronavirus vaccinations, looks on as Tokyo Medical Center director Kazuhiro Araki (C front) receives his third COVID-19 vaccine shot at the center in Tokyo on Dec. 1, 2021. (Pool photo)
            HEALTH-CORONAVIRUS/PORTUGAL

            HEALTH-CORONAVIRUS/PORTUGAL

            The third dose of the vaccine BioNTech-Pfizer to be administered against Covid-19, on November 4, 2021, in Lisbon, Portugal.The third dose of the vaccine began to be administered against covid-19 in Portugal, with priority being given to people aged 80 and over and users of homes and long-term care. (Photo by Nuno Cruz/NurPhoto) (Credit:Nuno Cruz/NurPhoto/Kyodo News Images)
              HEALTH-CORONAVIRUS/PORTUGAL

              HEALTH-CORONAVIRUS/PORTUGAL

              The third dose of the vaccine BioNTech-Pfizer to be administered against Covid-19, on November 4, 2021, in Lisbon, Portugal.The third dose of the vaccine began to be administered against covid-19 in Portugal, with priority being given to people aged 80 and over and users of homes and long-term care. (Photo by Nuno Cruz/NurPhoto) (Credit:Nuno Cruz/NurPhoto/Kyodo News Images)
                HEALTH-CORONAVIRUS/PORTUGAL

                HEALTH-CORONAVIRUS/PORTUGAL

                The third dose of the vaccine BioNTech-Pfizer to be administered against Covid-19, on November 4, 2021, in Lisbon, Portugal.The third dose of the vaccine began to be administered against covid-19 in Portugal, with priority being given to people aged 80 and over and users of homes and long-term care. (Photo by Nuno Cruz/NurPhoto) (Credit:Nuno Cruz/NurPhoto/Kyodo News Images)
                  COVID-19 vaccine developed by Moderna

                  COVID-19 vaccine developed by Moderna

                  Photo taken on May 24, 2021, shows a vial containing COVID-19 vaccine developed by Moderna Inc. in Sendai, Miyagi Prefecture, northeastern Japan.
                    COVID-19 mass vaccination center in Nagoya

                    COVID-19 mass vaccination center in Nagoya

                    People wait to receive coronavirus vaccine shots at Vantelin Dome Nagoya, home of the Chunichi Dragons baseball club, in Nagoya, central Japan, on July 5, 2021. The stadium will be used as a mass vaccination center in the daytime until Sept. 30.
                      COVID-19 mass vaccination center in Nagoya

                      COVID-19 mass vaccination center in Nagoya

                      People wait to receive coronavirus vaccine shots at Vantelin Dome Nagoya, home of the Chunichi Dragons baseball club, in Nagoya, central Japan, on July 5, 2021. The stadium will be used as a mass vaccination center in the daytime until Sept. 30.